Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Muskoka Grown produces high-quality craft cannabis flower and pre-rolls, with a focus on small-batch production. The company has become one of Ontario’s top independent suppliers after emerging from bankruptcy to profitability between 2022–2024. Their average THC content exceeds 30%, yields have doubled, and sales quadrupled over the last year. They maintain strong market presence in Ontario but face challenges elsewhere.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Muskoka Grown.